Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study

Other recent posts

Blog

An introduction to participant recruitment in clinical trials

Participant recruitment in clinical trials is more than a formality; it plays a crucial role in the success of medical research. In this short guide, we explore what participant recruitment...

Read more

Article

A New Era in Respiratory Vaccines: The modRNA Breakthrough and the Power of Human Challenge Trials

Executive Summary As respiratory vaccines continue to impose significant burdens on healthcare systems around the world, vaccine development has entered a transformative era. This white paper explores the history of...

Read more

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Stay connected

Sign up to our emails and follow us on social media to keep up to date with hVIVO.